With insights into next-generation therapies, this discussion explores what’s ahead in the follicular lymphoma landscape. Ruemu Birhiray, MD of Hematology Oncology of Indiana leads the continuation of a roundtable discussion on FL treatment. Three experts analyze data on combination therapy for FL, including efficacy, safety, and strategy adoption.